Gahl GM - Search Results

1

Peritoneal dialysis fluid inhibition of phagocyte function: effects of osmolality and glucose concentration.

Liberek T, Topley N, Jörres A, Coles GA, Gahl GM, Williams JD. Liberek T, et al. Among authors: gahl gm. J Am Soc Nephrol. 1993 Feb;3(8):1508-15. doi: 10.1681/ASN.V381508. J Am Soc Nephrol. 1993. PMID: 8387831

2

Effect of glucose degradation products on human peritoneal mesothelial cell function.

Witowski J, Korybalska K, Wisniewska J, Breborowicz A, Gahl GM, Frei U, Passlick-Deetjen J, Jörres A. Witowski J, et al. Among authors: gahl gm. J Am Soc Nephrol. 2000 Apr;11(4):729-739. doi: 10.1681/ASN.V114729. J Am Soc Nephrol. 2000. PMID: 10752532

3

Peritoneal dialysis fluid inhibition of polymorphonuclear leukocyte respiratory burst activation is related to the lowering of intracellular pH.

Liberek T, Topley N, Jörres A, Petersen MM, Coles GA, Gahl GM, Williams JD. Liberek T, et al. Among authors: gahl gm. Nephron. 1993;65(2):260-5. doi: 10.1159/000187485. Nephron. 1993. PMID: 8247190

4

Inhibition of cytokine synthesis by peritoneal dialysate persists throughout the CAPD cycle.

Jörres A, Topley N, Steenweg L, Müller C, Köttgen E, Gahl GM. Jörres A, et al. Among authors: gahl gm. Am J Nephrol. 1992;12(1-2):80-5. doi: 10.1159/000168422. Am J Nephrol. 1992. PMID: 1415370

5

Prolonged exposure to glucose degradation products impairs viability and function of human peritoneal mesothelial cells.

Witowski J, Wisniewska J, Korybalska K, Bender TO, Breborowicz A, Gahl GM, Frei U, Passlick-Deetjen J, Jörres A. Witowski J, et al. Among authors: gahl gm. J Am Soc Nephrol. 2001 Nov;12(11):2434-2441. doi: 10.1681/ASN.V12112434. J Am Soc Nephrol. 2001. PMID: 11675420

6

Leukotriene release from peripheral and peritoneal leukocytes following exposure to peritoneal dialysis solutions.

Jörres A, Jörres D, Topley N, Gahl GM, Mahiout A. Jörres A, et al. Among authors: gahl gm. Nephrol Dial Transplant. 1991;6(7):495-501. doi: 10.1093/ndt/6.7.495. Nephrol Dial Transplant. 1991. PMID: 1922911

7

Peritoneal dialysis fluid biocompatibility: does it really matter?

Jörres A, Gahl GM, Frei U. Jörres A, et al. Among authors: gahl gm. Kidney Int Suppl. 1994 Dec;48:S79-86. Kidney Int Suppl. 1994. PMID: 7700046 Review. No abstract available.

8

Effect of peritoneal dialysis fluids on leukocyte function.

Jörres A, Gahl GM. Jörres A, et al. Among authors: gahl gm. Perit Dial Int. 1994;14 Suppl 3:S29-32. Perit Dial Int. 1994. PMID: 7948271 No abstract available.

9

In-vitro biocompatibility of alternative CAPD fluids; comparison of bicarbonate-buffered and glucose-polymer-based solutions.

Jörres A, Gahl GM, Topley N, Neubauer A, Ludat K, Müller C, Passlick-Deetjen J. Jörres A, et al. Among authors: gahl gm. Nephrol Dial Transplant. 1994;9(7):785-90. Nephrol Dial Transplant. 1994. PMID: 7970120

10

Impact of peritoneal dialysis solutions on peritoneal immune defense.

Jörres A, Topley N, Witowski J, Liberek T, Gahl GM. Jörres A, et al. Among authors: gahl gm. Perit Dial Int. 1993;13 Suppl 2:S291-4. Perit Dial Int. 1993. PMID: 8399591

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters